No alterations for ATLASTIN 1 protein levels in SPG3a-HSP patient cell lines were reported, while the availability for SPASTIN in the lower MNs derived from SPG4-HSP patient cell lines appeared significantly decreased. The gene discussed is SPAST; the disease is hereditary spastic paraplegia.